Why Omada Health, Inc.’s (OMDA) Stock Is Up 5.20%
As of Monday, August 10, Omada Health, Inc.’s OMDA share price has surged by 5.20%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Commentary & Analysis
Is Omada Health, Inc. (OMDA) Overvalued?
We dive into why Omada Health, Inc. (OMDA) could be considered overvalued on 2026-08-07, based on AAII’s Value Score and Grade.Rosalio Madrigal
Why Omada Health, Inc.’s (OMDA) Stock Is Up 11.34%
As of Friday, August 07, Omada Health, Inc.’s OMDA share price has surged by 11.34%, which has investors questioning if this is right time to sell.Michael Rose
Why Omada Health, Inc.’s (OMDA) Stock Is Up 17.20%
As of Friday, August 07, Omada Health, Inc.’s OMDA share price has surged by 17.20%, which has investors questioning if this is right time to sell.Tudor Pop
Why Omada Health, Inc.’s (OMDA) Stock Is Up 5.40%
As of Friday, June 26, Omada Health, Inc.’s OMDA share price has surged by 5.40%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Financial Summary
| Share Statistics | OMDA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,451.4 | $1,982.5 | 49% |
|
| Shares Out (Mil) | 63.9 | 77.7 | 53% |
|
| Institutional Ownership | 96.1% | 86.1% | 69% |
|
| Float (Mil) | 50.9 | 52.1 | 47% |
|
| Beta | na | 0.75 | na |
|
| Avg Daily Volume (000s) | 1,754 | 637 | 80% |
|
| Price Change (52-week) |
16.6% | 79.7% | 59% |
|
| Growth | OMDA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.9% | na |
|
| Net Income (5yr) | na | (1.6%) | na |
|
| EPS (5yr) | na | 0.3% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (17.9%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 5 | 5 | |
| Current EPS | $0.103 | $0.436 | $0.556 | |
| Month Ago EPS | $0.083 | $0.314 | $0.474 | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | $0.089 | $0.327 | $0.476 | |
| Year/Year Chg | 28.8% | (224.9%) | (324.1%) | |
| Financials | OMDA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $310 | $1,504 | 36% |
|
| Net Income (TTM) (Mil) | $4 | $28 | 42% |
|
| EPS (TTM) | $0.073 | $0.200 | 42% |
|
| Operating Cash Flow (TTM) (Mil) | $24 | $162 | 42% |
|
| Net Cash Flow (TTM) (Mil) | ($1) | $9 | 39% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $338 | 0% |
|
| Enterprise Value (Q1) (Mil) | $1,227 | $2,416 | 43% |
|
| Valuation | OMDA | Industry Median |
Percentile (All Stocks) |
|
| P/B | 5.69 | 2.79 | 81% |
|
| P/E | 324.8 | 25.8 | 99% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | OMDA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 68.2% | 27.8% | 79% |
|
| Net Margin | 1.4% | 1.2% | 36% |
|
| ROA | 1.4% | 2.2% | 51% |
|
| ROE | 1.8% | 7.2% | 38% |
|
| Liabilities to Assets | 23.0% | 58.6% | 15% |
|
| F-Score | 4 | 5 | 34% |
|
Passing Stock Screens
As of 8/20/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Driehaus Screen
Factors: Size, Momentum, Growth, Earnings Estimates
Classic momentum approach that seeks out stocks that are rapidly rising in price with the belief that the rising price will attract other investors.
| Performance Since Inception: | 13.3% |
| +/- S&P 500: | +5.8 |
FACTOR STRATEGY
Dual Cash Flow Screen
Factors: Quality, Growth
An analysis that can provide advance notice that a company may be facing financial trouble, though earnings and sales appear strong.
| Performance Since Inception: | 11.4% |
| +/- S&P 500: | +3.9 |
